Insider Ledger
DNLI insider buying and SEC filings, explained
Denali Therapeutics Inc. · CIK 1714899
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$973K
Planned sales (10b5-1)
$327K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 4, 2026 | Sale | Peter Scott Chin (Chief Medical Officer) sold 1,654 shares at about $22.29 ($37K). Holdings down 1% to 204,538 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 9, 2026 |
| Sep 2, 2026 | Planned (10b5-1) | Nancy Thornberry (Director) sold 11,439 shares at about $22.90 ($262K), marked as a 10b5-1 plan trade. Holdings down 37% to 19,686 shares. | SEC filing Filed Sep 4, 2026 |
| Sep 1, 2026 | Planned (10b5-1) | Alexander O. Schuth (COFO and Secretary) sold 2,768 shares at $23.44 ($65K), marked as a 10b5-1 plan trade. Holdings down 1% to 278,995 shares. | SEC filing Filed Sep 3, 2026 |
| Aug 11, 2026 | Sale | Alexander O. Schuth (COFO and Secretary) sold 2,857 shares at $25.07 ($72K). Holdings down 1% to 281,763 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 13, 2026 |
| Jan 6, 2026 | Sale | Alexander O. Schuth (COFO and Secretary) sold 17,218 shares at $16.50 ($284K). Holdings down 6% to 282,828 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 8, 2026 |
| Jan 6, 2026 | Sale | Ryan J. Watts (CEO and Director) sold 35,198 shares at $16.50 ($581K). Holdings down 11% to 296,833 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 8, 2026 |
| Dec 11, 2025 | Other purchase | Julian Baker (Director) bought 2,285,714 $0.01 Prefunded Warrants indirectly at $17.49 ($40.0M) in a public offering. Indirect holdings up 10% to 25,996,310 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 5 other reporting owners. | SEC filing Filed Dec 15, 2025 |
12 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 3, 2026, 4:03 PM ET 8-K | Earnings released (Item 2.02) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow DNLI in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.